Talk:Indonesian Food and Drug Authority

A Commons file used on this page has been nominated for deletion

The following Wikimedia Commons file used on this page has been nominated for deletion:

Participate in the deletion discussion at the nomination page. —Community Tech bot (talk) 18:52, 7 February 2019 (UTC)[reply]

Commons files used on this page or its Wikidata item have been nominated for deletion

The following Wikimedia Commons files used on this page or its Wikidata item have been nominated for deletion:

Participate in the deletion discussion at the nomination page. —Community Tech bot (talk) 08:17, 28 March 2021 (UTC)[reply]

Semi-protected edit request on 26 April 2022

Change the title from "National Agency of Drug and Food" to "Indonesian Food and Drug Authority". Organization Section must also be changed to reflect the newest regulation. MDA1896 (talk) 09:54, 26 April 2022 (UTC)[reply]

 Not done: please provide reliable sources that support the change you want to be made. ScottishFinnishRadish (talk) 10:43, 26 April 2022 (UTC)[reply]
Done, also added some context in the history section on the new name. Ckfasdf (talk) 01:42, 27 April 2022 (UTC)[reply]

Semi-protected edit request on 4 July 2025

Cite error: A <ref> tag is missing the closing </ref> (see the help page).[1]</ref></ref></ref>

Please make the following additions and corrections to the article:

1. **Add a new section after "History" and before "Task and function":**

COVID-19 Response

During the COVID-19 pandemic, the BPOM played a central role in the evaluation and authorization of COVID-19 vaccines and therapeutic drugs in Indonesia. In January 2021, BPOM approved the emergency use of the Sinovac vaccine, enabling the start of the country's mass vaccination program.[2] The agency also streamlined regulatory procedures to accelerate access to critical health products, working closely with national and international stakeholders.[3]

2. **In the first paragraph of "History", change:** "Operating under the auspices of the Dutch pharmaceutical company, DVG itself was in charge of producing chemical drugs as well as operating a pharmaceutical research center." to "Operating under the Dutch colonial administration, DVG was responsible for public health matters, including pharmaceutical production and research."

3. **Add the following to the end of the "Task and function" section:**

In recent years, BPOM has also implemented digital systems to support product registration and public access to information, including e-registration platforms and an online database of certified products.[4]

4. **Expand the "See also" section (if not already present) to include:**

 Not done: as this edit request appears to have been created using an AI chatbot, which is not permitted per WP:LLMTALK. Day Creature (talk) 16:37, 4 July 2025 (UTC)[reply]